Instadose Pharma Corp Stock Today
| INSD Stock | USD 0 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 5
|
Instadose Pharma is trading at 0.0011 as of the 1st of December 2024, a No Change since the beginning of the trading day. The stock's lowest day price was 0.0011. Instadose Pharma has under 5 % chance of experiencing financial distress over the next 2 years, but has generated negative returns over the last 90 days. Equity ratings for Instadose Pharma Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of November 2024 and ending today, the 1st of December 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Instadose Pharma Corp. engages in growing, cultivation, processing, and global distribution of medical-grade cannabinoid oil. The company was founded in 2017 and is based in Burlington, Canada. Instadose Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.. The company has 531.93 M outstanding shares. More on Instadose Pharma Corp
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Instadose Stock Highlights
| Old Name | Verimatrix Société anonyme | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||
Instadose Pharma Corp (INSD) is traded on OTCCE Exchange in USA and employs 4 people. Instadose Pharma is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 585.13 K. Instadose Pharma Corp conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 531.93 M outstanding shares.
Instadose Pharma Corp currently holds about 5.33 K in cash with (65) of positive cash flow from operations.
Check Instadose Pharma Probability Of Bankruptcy
Ownership AllocationInstadose Pharma Corp has a total of 531.93 Million outstanding shares. Instadose Pharma secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Instadose Ownership Details
Instadose Stock Against Markets
Instadose Pharma Corporate Management
| Antonio Franchino | CEO Chairman | Profile | |
| LLB JD | Chief Officer | Profile | |
| Grant Sanders | Founder Officer | Profile | |
| Lawrence Acton | Chief Officer | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Instadose Pharma Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Instadose Pharma. If investors know Instadose will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Instadose Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.01) | Return On Assets (694.06) |
The market value of Instadose Pharma Corp is measured differently than its book value, which is the value of Instadose that is recorded on the company's balance sheet. Investors also form their own opinion of Instadose Pharma's value that differs from its market value or its book value, called intrinsic value, which is Instadose Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Instadose Pharma's market value can be influenced by many factors that don't directly affect Instadose Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Instadose Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Instadose Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Instadose Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.